These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
509 related articles for article (PubMed ID: 12526218)
1. [Expression of cyclooxygenase-2 in human transitional cell bladder carcinomas]. Zhan J; Tang XD Ai Zheng; 2002 Nov; 21(11):1212-6. PubMed ID: 12526218 [TBL] [Abstract][Full Text] [Related]
2. Expression of cyclooxygenase-2 in patients with bladder carcinoma. Yoshimura R; Sano H; Mitsuhashi M; Kohno M; Chargui J; Wada S J Urol; 2001 May; 165(5):1468-72. PubMed ID: 11342898 [TBL] [Abstract][Full Text] [Related]
3. [Expression of cyclooxygenase in bladder transitional cell carcinoma]. Wang KJ; Li H; Wei Q; Yang YR Sichuan Da Xue Xue Bao Yi Xue Ban; 2004 Jan; 35(1):54-6. PubMed ID: 14981815 [TBL] [Abstract][Full Text] [Related]
4. [The significance of the expression of cyclooxygenase-2 in bladder transitional cell carcinoma tissues]. Ren L; Hou SK; He LF; Ye HY; Guan KP Zhonghua Wai Ke Za Zhi; 2004 Sep; 42(18):1104-7. PubMed ID: 15498296 [TBL] [Abstract][Full Text] [Related]
5. Cyclooxygenase-2 expression in human breast cancers and adjacent ductal carcinoma in situ. Half E; Tang XM; Gwyn K; Sahin A; Wathen K; Sinicrope FA Cancer Res; 2002 Mar; 62(6):1676-81. PubMed ID: 11912139 [TBL] [Abstract][Full Text] [Related]
6. [Clinicopathologic significance of cyclooxygenase-2 mRNA expression in human breast carcinoma]. Pang D; Zhao X; Xue Y Zhonghua Zhong Liu Za Zhi; 2002 Nov; 24(6):567-9. PubMed ID: 12667327 [TBL] [Abstract][Full Text] [Related]
7. Cyclooxygenase-2 is highly expressed in carcinoma in situ and T1 transitional cell carcinoma of the bladder. Shariat SF; Kim JH; Ayala GE; Kho K; Wheeler TM; Lerner SP J Urol; 2003 Mar; 169(3):938-42. PubMed ID: 12576817 [TBL] [Abstract][Full Text] [Related]
8. [Cyclooxygenase-2-expression in bladder cancer: tumor-biological and clinical implications]. Wülfing C; Eltze E; Von Struensee D; Wülfing P; Bode ME; Bettendorf O; Piechota H; Hertle L Aktuelle Urol; 2004 Aug; 35(4):331-8. PubMed ID: 15459875 [TBL] [Abstract][Full Text] [Related]
9. Cyclooxygenase-2 expression on urothelial and inflammatory cells of cystoscopic biopsies and urine cytology as a possible predictive marker for bladder carcinoma. Moussa M; Omran Z; Nosseir M; Lotfy A; Swellam T APMIS; 2009 Jan; 117(1):45-52. PubMed ID: 19161536 [TBL] [Abstract][Full Text] [Related]
10. Cyclooxygenase-2 parallels invasive depth and increased MVD in transitional cell carcinoma. Li G; Yang T; Li L; Yan J; Zeng Y; Yu J; Zhang Y Colloids Surf B Biointerfaces; 2004 Aug; 37(1-2):15-9. PubMed ID: 15450303 [TBL] [Abstract][Full Text] [Related]
11. Alteration of the vascular endothelial growth factor and angiopoietins-1 and -2 pathways in transitional cell carcinomas of the urinary bladder associated with tumor progression. Quentin T; Schlott T; Korabiowska M; Käthei N; Zöller G; Glaser F; Kunze E Anticancer Res; 2004; 24(5A):2745-56. PubMed ID: 15517881 [TBL] [Abstract][Full Text] [Related]
12. Cyclooxygenase-2 is up-regulated in proliferative inflammatory atrophy of the prostate, but not in prostate carcinoma. Zha S; Gage WR; Sauvageot J; Saria EA; Putzi MJ; Ewing CM; Faith DA; Nelson WG; De Marzo AM; Isaacs WB Cancer Res; 2001 Dec; 61(24):8617-23. PubMed ID: 11751373 [TBL] [Abstract][Full Text] [Related]
13. Expression of cyclooxygenase-2 in primary superficial bladder cancer tissue may predict risk of its recurrence after complete transurethral resection. Okajima E; Uemura H; Ohnishi S; Tanaka M; Ohta M; Tani M; Fujimoto K; Ozono S; Okajima E; Hirao Y Aktuelle Urol; 2003 Jul; 34(4):256-8. PubMed ID: 14566678 [TBL] [Abstract][Full Text] [Related]
14. Correlation of cyclooxygenase-2 expression with molecular markers, pathological features and clinical outcome of transitional cell carcinoma of the bladder. Shariat SF; Matsumoto K; Kim J; Ayala GE; Zhou JH; Jian W; Benedict WF; Lerner S J Urol; 2003 Sep; 170(3):985-9. PubMed ID: 12913755 [TBL] [Abstract][Full Text] [Related]
15. [Expressions of MMP-2 and COX-2 mRNA in bladder transitional cell carcinoma and their correlation]. Zhang HP; Yu B; Zheng XD; Hu HJ; Gao ZB; Li L; Zhou LF Zhonghua Nan Ke Xue; 2008 Nov; 14(11):1011-4. PubMed ID: 19102503 [TBL] [Abstract][Full Text] [Related]
16. Molecular basis of colorectal cancer - role of gastrin and cyclooxygenase-2. Hartwich J; Konturek SJ; Pierzchalski P; Zuchowicz M; Konturek PC; Bielański W; Marlicz K; Starzyńska T; Ławniczak M Med Sci Monit; 2001; 7(6):1171-81. PubMed ID: 11687726 [TBL] [Abstract][Full Text] [Related]
17. A cox-2 promoter-based replication-selective adenoviral vector to target the cox-2-expressing human bladder cancer cells. Shirakawa T; Hamada K; Zhang Z; Okada H; Tagawa M; Kamidono S; Kawabata M; Gotoh A Clin Cancer Res; 2004 Jul; 10(13):4342-8. PubMed ID: 15240520 [TBL] [Abstract][Full Text] [Related]
18. Cytochrome P450 isoenzyme mRNA expression pattern in human urinary bladder malignancies and normal urothelium. Brauers A; Manegold E; Buettner R; Baron JM; Merk HF; Jakse G Cancer Detect Prev; 2000; 24(4):356-63. PubMed ID: 11059566 [TBL] [Abstract][Full Text] [Related]
19. Enhanced expression of cyclooxygenase-2 in high grade human transitional cell bladder carcinomas. Kömhoff M; Guan Y; Shappell HW; Davis L; Jack G; Shyr Y; Koch MO; Shappell SB; Breyer MD Am J Pathol; 2000 Jul; 157(1):29-35. PubMed ID: 10880372 [TBL] [Abstract][Full Text] [Related]
20. Early expression of cyclo-oxygenase-2 during sporadic colorectal carcinogenesis. Hao X; Bishop AE; Wallace M; Wang H; Willcocks TC; Maclouf J; Polak JM; Knight S; Talbot IC J Pathol; 1999 Feb; 187(3):295-301. PubMed ID: 10398082 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]